新股暗盤 | 康龍化成(3759.HK)暗盤段漲逾5%
格隆匯11月27日丨據輝立證券,康龍化成(3759.HK)暗盤段現報41.5港元,較發行價39.5港元漲5.06%。公司是一家領先的全流程一體化醫藥研發服務平台,業務遍及全球,致力於協助客户加速藥物創新。根據弗若斯特沙利文的資料,按2018年的總收益計,公司是中國第二大醫藥研發服務平台及全球三大藥物發現服務供應商之一。2016年至2018年收益分別為16.34億、22.94億、29.08億元人民幣,溢利分別為1.71億、2.18億、3.35億元人民幣;2018歷史市盈率66.5-76.1x。公司此次發售1.17億股,其中香港發售5826.81萬股,國際發售5826.8萬股,每手100股,淨籌約43.44億港元;公開發售獲114.23倍認購。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.